Rita Chuang
Family Medicine · Henderson, NVNPI 1497854962
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,370 of the $15,371 with a category attached, or 87.0%. It is spread thinly across 55 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $4,840 and has fallen 81.9% since, to $876 in 2025. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 479 payments — averaging $32.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- AstraZeneca$2K
- Amgen$1K
- Pfizer$1K
- GSK$665
- Novo Nordisk$494
- plus $7K from 49 others
Across 331 payments — averaging $1394.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$208K
- AstraZeneca$64K
- AbbVie$52K
- Ironwood Pharmaceuticals, Inc$43K
- Regeneron$39K
- Boehringer Ingelheim$26K
- plus $29K from 4 others
What the payments were for
- Consulting fees$250%
- Speaking & faculty fees$2001%
- Travel & lodging$1,53610%
- Food & beverage$13,37087%
- Education$1311%
- Gifts$1001%
- Entertainment$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,371 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha PushtronexEvolocumab | 11 | $6,585 |
| BreynaBudesonide/Formoterol Fumarate | 11 | $1,326 |
| Levothyroxine Sodium | 123 | $1,284 |
| Atorvastatin Calcium | 85 | $1,117 |
| Finasteride | 15 | $444 |
| Pravastatin Sodium | 39 | $437 |
| Amlodipine Besylate | 62 | $379 |
| Montelukast Sodium | 21 | $342 |
| Omeprazole | 29 | $309 |
| Rosuvastatin Calcium | 37 | $291 |
| Simvastatin | 34 | $266 |
| Losartan Potassium | 55 | $258 |
| Metformin Hcl | 29 | $229 |
| Alendronate Sodium | 31 | $228 |
| Gabapentin | 13 | $227 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Henderson
- Badi EghterafiHenderson$38K
- Gautham ReddyHenderson$17K
- Yuan-Chung ChenHenderson$13K
- Travis HailstoneHenderson$8K
- Elena GarciaHenderson$7K
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Bayo Curry-WinchellReno$74K
- Warren MagnusLas Vegas$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.